report
aristeromycin
fluorinatedaristeromycin
analogu
activ
rna
virus
middl
east
respiratori
syndrom
coronaviru
merscov
sever
acut
respiratori
syndrom
coronaviru
sarscov
zika
viru
zikv
chikungunya
viru
chikv
howev
exhibit
substanti
cytotox
cytotox
may
attribut
phosphoryl
design
synthes
onecarbon
homolog
fluorinatedaristeromycin
analogu
modif
prevent
phosphorly
cellular
kinas
wherea
inhibitori
activ
toward
sadenosyllhomocystein
sah
hydrolas
retain
enantiomer
pure
homoaristeromycin
analogu
synthes
via
electrophil
fluorin
silyl
enol
ether
selectfluor
use
basebuild
approach
key
step
synthes
compound
exhibit
potent
inhibitori
activ
toward
sah
hydrolas
among
bfluoroadenosin
analogu
potent
ic
mm
among
compound
test
bfluorohomoaristeromycin
show
potent
antivir
activ
ec
mm
chikv
without
notic
cytotox
mm
display
antichikv
activ
wherea
inhibit
sah
hydrolas
similar
ic
valu
mm
respect
suggest
antivir
activ
mere
depend
inhibit
sah
hydrolas
support
fact
antivir
effect
specif
chikv
alphavirus
none
homolog
analogu
inhibit
rna
virus
sarscov
merscov
zikv
potent
inhibit
high
select
index
make
bfluorohomoaristeromycin
promis
new
templat
develop
antivir
chikv
seriou
reemerg
pathogen
infect
million
peopl
past
year
rna
virus
rna
genet
materi
mani
import
human
pathogen
singlestrand
rna
ssrna
genom
baltimor
classif
distinguish
three
group
rna
virus
base
natur
genom
mode
replic
doublestrand
rna
virus
negativesens
ssrna
virus
positivesens
ssrna
virus
virus
form
largest
group
contain
mani
import
human
pathogen
dengu
viru
hepat
c
viru
sever
acut
respiratori
syndrom
sar
coronaviru
middl
east
respiratori
syndrom
mer
coronaviru
zika
viru
zikv
chikungunya
viru
chikv
antivir
therapi
still
lack
virus
seriou
impact
human
health
thu
desir
develop
new
antivir
agent
treatment
viral
diseas
caus
rna
virus
genom
viru
function
messeng
rna
mrna
directli
translat
host
ribosom
viral
poli
protein
ultim
form
replic
complex
drive
replic
viral
rna
end
genom
virus
contain
cap
structur
import
translat
rna
stabil
evas
host
innat
immun
respons
cap
viral
rna
usual
carri
one
multipl
viral
protein
use
sadenosylmethionin
sam
methyl
donor
cellular
sadenosylhomocystein
sah
hydrolas
pivot
enzym
regener
cycl
sam
serv
methyl
donor
cellular
methyl
reaction
requir
viral
mrna
cap
inhibit
sah
hydrolas
lead
accumul
sah
turn
inhibit
samdepend
methyl
reaction
includ
requir
matur
viral
rna
thu
sah
hydrolas
promis
target
develop
broadspectrum
antivir
agent
varieti
carbocycl
adenosin
analogu
antivir
activ
includ
aristeromycin
assum
exert
antivir
action
via
inhibit
sah
hydrolas
close
correl
detect
antivir
effect
variou
carbocycl
acycl
adenosin
analogu
inhibitori
effect
sah
hydrolas
biochem
assay
purifi
protein
compound
observ
weak
inhibitor
flaviviru
replic
plaqu
reduct
assay
wherea
exhibit
potent
antivir
activ
replic
ss
rna
virus
ebola
among
aristeromycin
fig
repres
carbocycl
nucleosid
first
synthes
racem
form
shortli
thereaft
isol
ferment
broth
streptomyc
citricolor
display
potent
antivir
activ
sever
rna
virus
result
inhibit
sah
hydrolas
although
potent
sah
hydrolas
inhibitor
therapeut
util
limit
signific
toxic
cytotox
may
caus
compound
inhibit
cellular
rna
polymeras
andor
incorpor
cellular
rna
base
potent
antivir
activ
recent
report
synthesi
enantiomer
pure
fluorinatedaristeromycin
analogu
potent
antirna
viru
activ
among
difluoroaristeromycin
exhibit
potent
antivir
activ
merscov
sarscov
zikv
chikv
howev
compound
still
exhibit
substanti
cytotox
although
less
cytotox
cytotox
may
attribut
phosphoryl
similar
presum
therefor
desir
design
aristeromycin
analogu
retain
inhibitori
activ
toward
sah
hydrolas
without
phosphoryl
cellular
kinas
therefor
strategi
design
homolog
analogu
expect
displac
phosphatesuscept
hydroxyl
phosphatetransf
zone
kinas
feasibl
strategi
support
fact
homoaristeromycin
inact
possibl
due
failur
phosphoryl
thu
design
synthes
homoaristeromycin
analogu
combin
onecarbon
homolog
posit
bioisoster
displac
hydrogen
fluorin
posit
expect
compound
would
retain
inhibitori
activ
sah
hydrolas
wherea
lack
would
lead
lower
cytotox
report
synthesi
enantiomer
pure
homoaristeromycin
analogu
via
electrophil
fluorin
silyl
enol
ether
selectfluor
key
step
assess
antivir
activ
synthes
final
nucleosid
design
retrosynthet
analysi
illustr
scheme
final
nucleosid
deriv
amino
intermedi
linear
purin
base
buildup
approach
amino
deriv
easili
deriv
keton
via
stereoselect
reduct
keton
n
displac
azid
key
step
synthes
use
stereoselect
electrophil
fluorin
silyl
enol
ether
obtain
key
intermedi
keton
deriv
dcyclopentenon
use
michael
reaction
key
step
intermedi
effici
deriv
dribos
accord
previous
publish
procedur
minor
modif
key
intermedi
synthes
accord
previous
publish
procedur
shown
scheme
briefli
dribos
convert
dien
four
step
without
purif
yield
ringclos
metathesi
rcm
reaction
neolyst
instead
grubb
catalyst
follow
pyridinium
dichrom
pdc
oxid
afford
cyclopentenon
yield
modifi
procedur
creat
desir
intermedi
six
step
overal
yield
michael
addit
vinylmagnesium
bromid
presenc
copper
bromid
afford
vinyl
keton
yield
reduct
sodium
borohydrid
yield
aalcohol
singl
stereoisom
protect
tertbutyldiphenylsilyl
tbdp
group
yield
hydroborationoxid
boranedimethyl
sulphid
complex
afford
primari
alcohol
remov
tbdp
group
tetranbutylammonium
fluorid
tbaf
yield
diol
primari
hydroxyl
group
select
protect
tbdp
group
afford
oxid
remain
secondari
alcohol
tetranpropylammonium
perruthen
tpap
nmethylmorpholin
noxid
nmo
afford
keton
serv
key
start
materi
electrophil
fluorin
keton
convert
amin
key
precursor
synthesi
final
nucleosid
shown
scheme
keton
treat
lithium
bi
trimethylsilyl
amid
lihmd
follow
trap
result
enol
chlorotriethylsilan
tescl
produc
silyl
enol
ether
silyl
enol
ether
treat
electrophil
fluorin
octan
ditetrafluorobor
produc
desir
singl
stereoisom
equilibr
gemin
diol
electroneg
fluorin
atom
b
stereochemistri
fluorin
obtain
steric
hindranc
group
confirm
longrang
coupl
bf
xray
crystallographi
convers
adenosin
deriv
keton
synthes
yield
use
procedur
fluoro
keton
reduc
sodium
borohydrid
produc
alcohol
respect
first
attempt
direct
condens
reaction
mitsunobu
condit
obtain
desir
nucleosid
fail
yield
desir
condens
product
direct
n
reaction
triflat
synthes
anion
also
unsuccess
thu
decid
util
linear
purin
base
buildup
approach
n
displac
triflat
linear
less
bulki
power
nucleophil
nan
proceed
smoothli
yield
azido
deriv
respect
catalyt
reduct
pdc
yield
amin
respect
treat
triethylamin
nbutanol
microwav
irradi
yield
scheme
howev
weaker
nucleophil
give
desir
product
microwav
condit
thu
use
stronger
electrophil
rather
afford
desir
product
good
yield
cyclis
diethoxymethyl
acet
yield
nucleosid
respect
proton
h
nmr
spectrum
split
doublet
small
coupl
constant
j
hz
result
longrang
coupl
bf
confirm
desir
stereochemistri
f
well
treatment
aqueou
trifluoroacet
acid
yield
nucleosid
respect
synthesi
adenosin
deriv
treat
satur
tertbutanol
ammonia
yield
wherea
convert
use
satur
methanol
ammonia
solut
steel
bomb
treatment
aqueou
methylamin
afford
n
methyladenosin
nucleosid
respect
hydrolysi
n
hcl
yield
inosin
deriv
structur
confirm
singlecryst
xray
crystallographi
fig
synthes
nucleosid
assay
inhibitori
activ
sah
hydrolas
well
antivir
activ
virus
merscov
sarscov
zikv
chikv
use
cytopath
effect
cpe
reduct
assay
tabl
fluorin
adenosin
analogu
n
exhibit
potent
inhibitori
activ
sah
hydrolas
difluoroadenosin
analogu
also
inhibit
sah
hydrolas
lesser
extent
exampl
bfluoroadenosin
analogu
time
potent
difluoroadenosin
analogu
similar
trend
observ
fluorinatedadenosin
analogu
n
bfluoron
methyladenosin
show
similar
inhibitori
activ
bfluoroadenosin
similar
trend
observ
difluoron
methyladenosin
howev
inosin
analogu
inhibit
sah
hydrolas
inhibitori
activ
observ
highest
dose
test
mm
among
compound
test
bfluorohomoaristeromycin
show
potent
antivir
activ
ec
mm
chikv
without
notic
cytotox
mm
highest
dose
test
antivir
activ
mere
seem
depend
inhibit
sah
hydrolas
inhibit
enzym
display
antichikv
activ
regular
bfluoroaristeromycin
inact
chikv
addit
although
difluoroaristeromycin
display
broadspectrum
antivir
activ
sever
rna
virus
includ
sarscov
merscov
chikv
zikv
correspond
homolog
analogu
exhibit
antivir
activ
despit
potent
inhibitori
activ
toward
sah
hydrolas
result
demonstr
factor
besid
inhibitori
activ
toward
sah
hydrolas
may
involv
antivir
activ
seri
detail
studi
antivir
activ
mode
action
publish
elsewher
kovacikova
et
al
submit
reduc
cytotox
fluorin
aristeromycin
analogu
like
due
phosphoryl
cellular
kinas
design
synthes
fluorin
homoaristeromycin
analogu
nucleosid
synthes
dribos
use
michael
reaction
stereoselect
electrophil
fluorin
linear
purin
base
buildup
key
step
among
compound
test
bfluorohomoaristeromycin
show
potent
antichikv
activ
ec
mm
without
notic
cytotox
concentr
mm
result
high
select
index
si
indic
one
carbon
homolog
may
prevent
phosphoryl
result
low
cytotox
homolog
effect
inhibitori
activ
toward
sah
hydrolas
compound
inhibit
enzym
similar
ic
valu
mm
antivir
activ
specif
chikv
lesser
extent
alphavirus
wherea
virus
shown
sensit
sah
hydrolas
inhibitor
suggest
potent
antichikv
activ
base
mere
inhibit
sah
hydrolas
studi
show
bfluorohomoaristeromycin
promis
new
templat
develop
antichikv
agent
scheme
synthesi
fluorin
homoaristeromycin
analogu
proton
h
carbon
c
h
nmr
spectra
obtain
bruker
av
mhz
amx
mhz
jeol
jnmeca
mhz
bruker
avanc
iii
mhz
spectromet
h
nmr
data
report
peak
multipl
singlet
doublet
dd
doublet
doublet
triplet
td
triplet
doublet
q
quartet
quin
quintet
bs
broad
singlet
multiplet
coupl
constant
report
hertz
chemic
shift
report
ppm
rel
solvent
peak
reaction
routin
carri
inert
atmospher
dri
nitrogen
ika
rct
basic
type
heat
mantl
use
provid
constant
heat
sourc
microwaveassist
reaction
carri
seal
vessel
use
biotag
usjpn
part
microwav
reactor
reaction
temperatur
monitor
extern
surfac
ir
sensor
high
resolut
mass
spectra
measur
electrosprayion
quadrupol
timeofflight
esiqtof
techniqu
melt
point
record
barnstead
electrotherm
instrument
uncorrect
reaction
check
thin
layer
chromatographi
kieselgel
merck
spot
detect
view
uv
light
color
char
dip
panisaldehyd
solut
crude
compound
purifi
column
chromatographi
silica
gel
kieselgel
mesh
merck
anhydr
solvent
redistil
cah
p
sodium
benzophenon
prior
reaction
stir
solut
g
mmol
anhydr
tetrahydrofuran
ml
c
nitrogen
atmospher
ad
chlorotrietylsilan
ml
mmol
lithium
bi
trimethylsilyl
amid
solut
tetrahydrofuran
ml
mmol
reaction
mixtur
stir
c
h
warm
c
quench
use
satur
aqueou
nh
cl
ml
solut
extract
ethyl
acet
ml
organ
layer
dri
use
anhydr
mgso
concentr
vacuo
give
crude
silyl
enol
ether
use
immedi
next
step
without
purif
stir
solut
crude
silyl
enol
ether
anhydr
acetonitril
ml
ad
g
mmol
c
reaction
mixtur
stir
h
c
dilut
brine
ml
extract
ethyl
acet
organ
layer
dri
anhydr
mgso
filter
concentr
vacuo
residu
purifi
silica
gel
column
chromatographi
hexan
ethyl
acet
give
g
colorless
oil
equilibr
diol
stir
solut
g
mmol
tetrahydrofuran
ml
slowli
ad
sodium
borohydrid
mg
mmol
c
reaction
mixtur
stir
c
h
c
h
mixtur
dilut
water
ml
extract
ethyl
acet
ml
organ
layer
dri
anhydr
mgso
filter
concentr
vacuo
residu
purifi
silica
gel
chromatographi
hexan
ethyl
acet
give
colorless
oil
stir
solut
g
mmol
anhydr
tetrahydrofuran
ml
c
n
atmospher
ad
triethylamin
ml
mmol
chlorotriethylsilan
ml
mmol
lithium
bi
trimethylsilyl
amid
solut
tetrahydrofuran
ml
mmol
reaction
mixtur
stir
room
temperatur
h
warm
c
quench
use
satur
aqueou
ammonium
chlorid
solut
solut
extract
ethyl
acet
ml
organ
layer
dri
anhydr
mgso
concentr
vacuo
give
crude
silyl
enol
ether
use
immedi
next
step
without
purif
stir
solut
crude
silyl
enol
ether
anhydr
acetonitril
ml
ad
solut
g
mmol
acetonitril
ml
c
reaction
mixtur
tabl
inhibitori
activ
toward
sah
hydrolas
antichikv
activ
vero
cell
nucleosid
sah
hydrolas
ic
mm
chikv
ec
mm
cc
mm
stir
overnight
room
temperatur
concentr
vacuo
dilut
ethyl
acet
ml
organ
layer
dri
anhydr
mgso
concentr
vacuo
residu
purifi
silica
gel
column
chromatographi
hexan
ethyl
acet
give
g
diol
stir
solut
g
mmol
tetrahydrofuran
ml
ad
sodium
borohydrid
g
mmol
c
period
min
reaction
mixtur
stir
c
h
neutral
glacial
acet
acid
dilut
water
ml
extract
ethyl
acet
ml
organ
layer
wash
brine
ml
dri
anhydr
mgso
concentr
vacuo
residu
purifi
silica
gel
column
chromatographi
hexan
ethyl
acet
give
colorless
oil
stir
solut
g
mmol
anhydr
pyridin
ml
ad
triflic
anhydrid
ml
mmol
c
reaction
mixtur
stir
c
h
quench
water
ml
concentr
vacuo
residu
dilut
ethyl
acet
ml
wash
aqueou
cuso
solut
ml
organ
layer
dri
anhydr
mgso
filter
concentr
vacuo
get
crude
triflat
use
immedi
next
step
without
purif
stir
solut
crude
triflat
anhydr
dmf
ml
ad
sodium
azid
g
mmol
room
temperatur
reaction
mixtur
stir
c
h
cool
room
temperatur
dilut
water
ml
solut
extract
diethyl
ether
ml
organ
layer
wash
water
ml
dri
anhydr
mgso
filter
concentr
vacuo
residu
purifi
silica
gel
column
chromatographi
hexan
ethyl
acet
give
colorless
oil
stir
solut
g
mmol
anhydr
pyridin
ml
ad
triflic
anhydrid
ml
mmol
c
reaction
mixtur
stir
c
h
quench
satur
aqueou
sodium
bicarbon
solut
ml
concentr
vacuo
get
crude
residu
dilut
ethyl
acet
ml
wash
aqueou
cuso
solut
extract
ethyl
acet
ml
organ
layer
wash
water
dri
mgso
concentr
vacuo
residu
purifi
silica
gel
column
chromatographi
hexan
ethyl
acet
give
triflat
use
immedi
next
step
stir
solut
triflat
anhydr
dmf
ml
ad
sodium
azid
g
mmol
room
temperatur
reaction
mixtur
stir
c
h
cool
room
temperatur
dilut
water
ml
mixtur
extract
diethyl
ether
ml
organ
layer
wash
water
ml
dri
anhydr
mgso
concentr
vacuo
residu
purifi
silica
gel
column
chromatographi
hexan
ethyl
acet
give
colorless
oil
stir
solut
g
mmol
methanol
ml
ad
palladium
carbon
wet
ca
water
mg
room
temperatur
reaction
mixtur
stir
h
h
complet
reaction
tlc
suspens
filter
pad
celit
concentr
give
amin
colorless
syrup
use
next
step
without
purif
solut
crude
g
mmol
nbutanol
ml
ad
n
ndiisopropylethylamin
room
temperatur
reaction
mixtur
subject
microwav
irradi
c
h
cool
room
temperatur
reaction
mixtur
concentr
vacuo
dilut
ethyl
acet
ml
wash
satur
aqueou
nahco
dri
anhydr
mgso
filter
concentr
vacuo
residu
purifi
silica
gel
chromatographi
hexan
ethyl
acet
give
colorless
oil
tertbutyldiphenylsilyl
oxi
ethyl
stir
mixtur
g
mmol
diethoxymethyl
acet
ml
heat
c
h
cool
room
temperatur
solvent
remov
reduc
pressur
residu
purifi
silica
gel
chromatographi
hexan
ethyl
acet
give
white
foam
g
c
nmr
mhz
cdcl
tertbutyldiphenylsilyl
oxi
ethyl
solut
g
mmol
methanol
ml
ad
palladium
carbon
wet
ca
water
mg
room
temperatur
reaction
mixtur
stir
h
atmospher
room
temperatur
overnight
suspens
filter
celit
concentr
give
amin
colorless
syrup
use
next
step
without
purif
stir
solut
crude
ml
ad
g
mmol
triethylamin
ml
mmol
reaction
mixtur
heat
reflux
cool
room
temperatur
solvent
remov
reduc
pressur
residu
use
next
step
without
purif
crude
ad
diethoxymethyl
acet
ml
reaction
mixtur
stir
c
overnight
solvent
remov
reduc
pressur
residu
purifi
silica
gel
column
chromatographi
hexan
ethyl
acet
give
j
hz
j
stir
solut
g
mmol
methanol
ml
ad
aqueou
trifluoroacet
acid
ml
c
reaction
mixtur
stir
room
temperatur
h
solvent
remov
reduc
pressur
residu
purifi
column
chromatographi
methylen
chlorid
methanol
give
g
crystal
diethyl
ethermethanol
white
solid
mp
c
c
ch
oh
uv
ch
oh
l
max
nm
h
nmr
mhz
cd
od
j
hz
dt
j
hz
hz
c
nmr
mhz
cd
od
j
hz
j
hz
stir
solut
g
mmol
ml
ad
aqueou
trifluoroacet
acid
solut
ml
c
reaction
mixtur
stir
room
temperatur
h
mixtur
concentr
vacuo
residu
purifi
silica
gel
column
chromatographi
methylen
chlorid
methanol
give
g
crystal
diethyl
ethermethanol
white
solid
mp
c
j
hz
ddd
j
j
hz
j
hz
c
nmr
mhz
cdcl
j
methylamino
solut
mg
mmol
methanol
ad
methylamin
aqueou
solut
reaction
mixtur
heat
c
h
steel
bomb
cool
room
temperatur
solvent
remov
reduc
pressur
residu
purifi
silica
gel
chromatographi
methylen
chlorid
methanol
give
mg
crystal
diethyl
ethermethanol
white
solid
mp
c
c
cyclopentyl
stir
solut
mg
mmol
ml
ad
n
hcl
ml
room
temperatur
reaction
mixtur
heat
reflux
overnight
cool
room
temperatur
concentr
vacuo
residu
purifi
reversephas
silica
gel
column
chromatographi
h
give
mg
crystal
diethyl
ethermethanol
white
solid
mp
c
solut
mg
g
mmol
satur
methanol
ammonia
ml
heat
c
overnight
steel
bomb
cool
room
temperatur
solvent
remov
reduc
pressur
residu
purifi
silica
gel
column
chromatographi
methylen
chlorid
methanol
obtain
g
base
recov
start
materi
crystal
diethyl
ethermethanol
white
solid
mp
c
methylamino
solut
mg
mmol
methanol
ml
ad
methylamin
aqueou
solut
ml
mmol
reaction
mixtur
heat
c
h
steel
bomb
cool
room
temperatur
solvent
remov
reduc
pressur
residu
purifi
silica
gel
column
chromatographi
methylen
chlorid
methanol
give
g
crystal
diethyl
ethermethanol
white
solid
mp
c
determin
antivir
activ
synthes
compound
calcul
ec
cc
done
describ
inhibit
purifi
sah
hydrolas
differ
compound
determin
ic
valu
done
previous
describ
author
declar
known
compet
financi
interest
person
relationship
could
appear
influenc
work
report
paper
